Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction.
about
Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Computational approaches for modeling GPCR dimerizationChanges in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters.Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR FunctionMolecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cellsA novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in β2-adrenergic receptor internalization and down-regulationQuantitative modeling of GRK-mediated beta2AR regulationEffects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signallingMechanism of allosteric regulation of β2-adrenergic receptor by cholesterol.Effects of integrin-mediated cell adhesion on plasma membrane lipid raft components and signaling.Confinement of β(1)- and β(2)-adrenergic receptors in the plasma membrane of cardiomyocyte-like H9c2 cells is mediated by selective interactions with PDZ domain and A-kinase anchoring proteins but not caveolae.Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational studyNanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitorsPlasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms.Cholesterol orientation and tilt modulus in DMPC bilayersSarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotectionFluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling.Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosisGenotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical OutcomesA Pluridimensional View of Biased Agonism.Two classes of cholesterol binding sites for the β2AR revealed by thermostability and NMR.Role of membrane microdomains in compartmentation of cAMP signaling.PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains.Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.Proteome Based Construction of the Lymphocyte Function-Associated Antigen 1 (LFA-1) Interactome in Human Dendritic Cells.Cell type-specific β2-adrenergic receptor clusters identified using photoactivated localization microscopy are not lipid raft related, but depend on actin cytoskeleton integrity.Interaction with caveolin-1 modulates G protein coupling of mouse β3-adrenoceptor.Sensitivity of cholecystokinin receptors to membrane cholesterol content.Indacaterol in chronic obstructive pulmonary disease: an update for clinicians.Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts.Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity.The membrane protein LeuT in micellar systems: aggregation dynamics and detergent binding to the S2 site.Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domainsMembrane rafts and caveolae in cardiovascular signalingDifferential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclaseCaveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling.Cholesterol modulates the dimer interface of the β₂-adrenergic receptor via cholesterol occupancy sites.Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.Nanoscale membrane organization: where biochemistry meets advanced microscopy.
P2860
Q24630645-A9C47B49-96B7-4123-9985-491601B5AB51Q27001137-E7B8185C-51C5-4D24-9D3F-FD35C8313E46Q27350099-088C4B0D-73A2-4E72-AEB7-5A88A9DCA4AAQ28072820-63195A0F-EE3B-475D-B90F-B9C997CD1176Q28083146-9D06C09B-5AF6-4942-85A6-6E660CAB1327Q28258154-D7782BED-33E5-4865-A0EA-C1EC412B0415Q28472427-86B35657-30A6-4002-B81B-8F52A5B74F9AQ28572239-B0077FCE-088D-4A5E-98A2-6991656236AFQ30395783-6B7CB8C3-4BA1-45D8-ABE7-3F0693245A27Q30429614-32D2175C-DFF1-4BF7-98AC-43106B4AC8F7Q30503440-7E2177C8-0F8F-420F-AAFF-D0E98394DC09Q33492319-6BAA0A5D-D5A5-43C2-B997-00F02BD4C7A2Q33661563-5748D477-BA1E-4ADE-82C3-FBAD98C1EC92Q34020587-BF7D119E-DAF6-4020-A851-FEFC97945EEEQ34056688-1807097C-501B-40A4-B2C5-F8649F075D8AQ34201061-ADF57BF3-5BE7-4A2E-9819-5A9349751A2FQ34345068-DA32F16C-ABDA-4832-88A8-1DBAED046758Q34514108-87C825F3-D7BC-4BD5-BC46-13ECEF0463FEQ34534212-5558D7EF-24B9-404E-9AD8-E74B1CBDA5F6Q34540545-13305E1B-A0C6-4C11-8C3E-417B3C9B256AQ34561283-519896F6-8C59-4A10-A505-DCA04AF13B2AQ35154256-98679743-17F9-4413-9B44-42B818F41445Q35197975-FE44ED14-2F1E-48BC-98F9-A3C66211A88CQ35625928-3CC86449-9FD2-4B1F-91A6-8D9507C6C523Q35927007-CBA5AB86-5737-4833-8CDF-BE40517E3725Q35956657-063C9858-FB54-4364-8962-00A320A7C7AEQ36016991-06CD092D-BEF1-450B-B236-EE27DF2FD473Q36329391-9BE605A2-7FEB-4444-9FDE-7DCF10583D51Q36443777-39EC85D6-E400-4E27-9439-88315359069DQ36497422-94ECD1D6-A1E5-4114-9B27-4D0B2EC6BEA8Q37183472-3B81B2FD-E9BF-45BD-9D73-D3B1B5455CCAQ37210872-DD1F7FE6-A046-4A7E-81E7-7FA16A75BE8FQ37272208-3A455531-64B9-447D-A5E5-FE69AC276311Q37349045-104C4DB0-B936-4868-BB7C-E71B38491254Q37372214-F7F716AB-8970-4563-A8B6-F45866F397D1Q37415804-1B6EE242-8B04-4087-9A08-213D4393291EQ37700209-F2077964-37B1-45C3-9738-3A687B4510D1Q37804908-8D6C13AD-4479-4E77-B50C-14D46F045B0BQ37842745-DFC5CF86-6227-40DF-AAFC-60FEF0B3BD72Q37946455-BB3625AB-8A52-4269-A151-E66D6DF6D30E
P2860
Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cholesterol-dependent separati ...... zation of signal transduction.
@en
Cholesterol-dependent separati ...... zation of signal transduction.
@nl
type
label
Cholesterol-dependent separati ...... zation of signal transduction.
@en
Cholesterol-dependent separati ...... zation of signal transduction.
@nl
prefLabel
Cholesterol-dependent separati ...... zation of signal transduction.
@en
Cholesterol-dependent separati ...... zation of signal transduction.
@nl
P2093
P2860
P356
P1476
Cholesterol-dependent separati ...... zation of signal transduction.
@en
P2093
Andreas Breit
Céline Galés
Stéphanie M Pontier
Ségolène Galandrin
P2860
P304
24659-24672
P356
10.1074/JBC.M800778200
P407
P577
2008-06-19T00:00:00Z